Diabetes

Canadian Task Force on Preventive Health Care

Recommendation Table

Preventive Health Care, 2005 Update: Screening for Type 2 Diabetes Mellitus to Prevent Vascular Complications

Prepared by D.S. Feig, MD, MSc, FRCPC, V.A. Palda, MD, MSc, FRCPC, L. Lipscombe, with the Canadian Task Force on Preventive Health Care

MANEUVER RECOMMENDATION

Screening adults with hypertension
There is fair evidence to recommend screening adults with hypertension for type 2 diabetes mellitus to prevent cardiovascular events and death (grade B recommendation).

Screening adults with hyperlipidemia There is fair evidence to recommend screening adults with hyperlipidemia for type 2 diabetes to prevent cardiovascular events and death (grade B recommendation).

Lifestyle interventions for overweight individuals with impaired glucose tolerance to reduce incidence of progression to diabetes There is good evidence to recommend lifestyle interventions for overweight individuals (body mass index > 25 kg/m2, or > 22 kg/m2 if of Asian descent) with impaired glucose tolerance to reduce the incidence of progression to diabetes (grade B recommendation).

Acarbose treatment for overweight individuals with impaired glucose tolerance to prevent cardiovascular events and hypertension There is fair evidence to recommend acarbose treatment for overweight individuals (as described above) with impaired glucose tolerance to prevent cardiovascular events and hypertension (grade B recommendation).

Metformin or acarbose treatment for overweight individuals with impaired glucose tolerance to prevent diabetes progression There is insufficient evidence to recommend metformin or acarbose treatment for overweight individuals (as described above) with impaired glucose tolerance to prevent diabetes progression (grade I recommendation).

Link to Published Recommendation Statement

Link to Full Technical Report (in pdf)

Link to Selected References list of this review

Top of Page

CTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 2000 Canadian Medical Association.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: February 02, 2005

MANEUVER	RECOMMENDATION
Screening adults with hypertension	There is fair evidence to recommend screening adults with hypertension for type 2 diabetes mellitus to prevent cardiovascular events and death (grade B recommendation).
Screening adults with hyperlipidemia	There is fair evidence to recommend screening adults with hyperlipidemia for type 2 diabetes to prevent cardiovascular events and death (grade B recommendation).
Lifestyle interventions for overweight individuals with impaired glucose tolerance to reduce incidence of progression to diabetes	There is good evidence to recommend lifestyle interventions for overweight individuals (body mass index > 25 kg/m2, or > 22 kg/m2 if of Asian descent) with impaired glucose tolerance to reduce the incidence of progression to diabetes (grade B recommendation).
Acarbose treatment for overweight individuals with impaired glucose tolerance to prevent cardiovascular events and hypertension	There is fair evidence to recommend acarbose treatment for overweight individuals (as described above) with impaired glucose tolerance to prevent cardiovascular events and hypertension (grade B recommendation).
Metformin or acarbose treatment for overweight individuals with impaired glucose tolerance to prevent diabetes progression	There is insufficient evidence to recommend metformin or acarbose treatment for overweight individuals (as described above) with impaired glucose tolerance to prevent diabetes progression (grade I recommendation).